OUR CONTRACT PHARMACEUTICAL SERVICES

Company Overview

OUR CONTRACT PHARMACEUTICAL SERVICES

We create robust formulation development strategies tailored to the characteristics of each individual API.

Read MoreWatch Now

Within Quay Pharma we can provide virtually all of the services required to bring drug products through the various stages of clinical development quickly and cost-effectively.

Quay Pharma has the expertise to give each product the best possible chance of success by optimising its delivery mechanism. Our experienced analytical team is on hand to provide all the support required through each stage of development and manufacture.

With clearly set out costs for specific stages, our cost structure is transparent and we can contribute from the preclinical stage, formulation, dosage form development and optimisation. In addition, we can provide a full manufacturing and packaging service covering Phase I, Phase II and small-scale Phase III from our accredited GMP facilities.

By drawing on our considerable experience of developing new dosage forms for new indications or different patient populations, we can also help organisations who want to reformulate or reposition existing drug products using our services. In addition, our GMP capabilities can be used for scale-up manufacturing, specials manufacturing and even small-scale commercial manufacturing.

Advantages of Quay Pharma

  • Our focus is always what the clients’ requirements are
  • Bespoke solutions to ensure on-time clinical delivery
  • Proven heritage and reliable service delivery since 2002
  • Total commitment to innovation and investment
  • We invest in the best, only experts with scientific backgrounds
Our Pharmaceutical Services

Preclinical Formulation

Robust formulation development strategies tailored to the characteristics of each individual API.

Find Out More

Pharmaceutical Preformulation

Analysis of Active Pharmaceutical Ingredients (APIs), including those that present particular challenges.

Find Out More

Pharmaceutical Formulation Development

Dosage form optimisation for a wide range of product types including those that have poor solubility or bioavailability.

Find Out More

Analytical Services

Analytical specialists working alongside our formulation and manufacturing teams which provide expert advice.

Find Out More

Phase I Clinical Manufacturing

Early clinical formulations and clinical manufacturing of First in Human trials and clinical evaluations of your API.

Find Out More

Phase II & III Clinical Manufacturing

Fully equipped and accredited to manufacture a wide range of products for Phase II and small-scale Phase III trials.

Find Out More

Commercial Manufacture & Packaging

MHRA licensed to include commercial manufacture. Services include contract packaging and assembly...

Find Out More

Clinical Trial Supply

Complete range of clinical trial supply packaging for solid and liquid dosages. Despatched with full QP release certification.

Find Out More

Live Biotherapeutics Drug Delivery

One of the few companies licensed for the clinical manufacture of live biotherapeutics products.

Find Out More

Orphan Drugs

Perfectly equipped to deliver an Orphan Drug molecule from preclinical and formulation development to small scale commercialisation.

Find Out More

Specials Manufacturing

One of the limited number of contract manufacturers who hold an MRHA license for the manufacture and supply of ‘specials’.

Find Out More
Your Dedicated Contacts
Maura McArdle
Head of Business Development
(Formulation Development)
Contact

Maura McArdle joined Quay as Head of Business Development for Europe in 2019. Maura’s appointment is to ensure continued focus on Quay’s core business, Pharmaceutical Development of small molecule compounds. With a degree in Chemical Engineering, Maura has over 20 years of business development experience into the Chemical and Pharmaceutical industries having previously worked for Almac, Brenntag and BASF.

Contact
Michael Kruidenier
Head of Business Development
(Live-Biotherapeutics)
Contact

Michael joined Quay Pharma in Sept 2013 and he is responsible for all global Live Biotherapeutic business and for all other business outside Europe. Most of Michael’s career has been spent in commercial roles. He has over 30 years of Sales and Marketing experience, including 20 years in the pharmaceutical industry with Proctor & Gamble and SCA followed by working for leading contract service organisations PERA and Penn Pharma.

Contact
Dr Audrey Vardy
Head of Business Development
(Preclinical)
Contact

Audrey has 15 years’ experience within the preclinical contract research world holding both Operational and Commercial positions during that time. Spending six years at CXR Biosciences, Audrey was a laboratory team leader, before joining the sales team as BDM, then Sales Manager. She then joined BD Biosciences as their European Key Account Manager is responsible for both contract services and drug metabolism research products.

Contact

Let's Talk Project Success

Talk directly to the Quay staff - Our dedicated team leaders are ready to listen and help with your project.

Contact Us